In the context of hepatic dysfunction, the removal of cytokines and hydrophobic, albumin‐bound hepatic toxins, such as bilirubin, bile acids, and amino acids, may have a beneficial effect on the clinical course of patients in liver failure [1]. The gene discussed is ALB; the disease is liver failure.